Critical Survey: iSpecimen (NASDAQ:ISPC) vs. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ: PGNY - Get Free Report) and iSpecimen (NASDAQ: ISPC - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Profitability This table compares Progyny and iSpecimen's net margins,